ABSTRACT
SCOPE: The impacts of longevity-promoting probiotic Bifidobacterium animalis subsp. lactis LKM512 (LKM512) on metabolic disease remain unclear. Here, the authors aim to explore the potential of LKM512 on the host physiological function and gut microbiota in high-fat diet-induced obese mice. METHODS AND RESULTS: LKM512 are orally administrated for 12 weeks, and the effects of LKM 512 on systemic inflammation and insulin resistance, as well as gut microbiota, are investigated in high-fat (HF) diet-induced obese mice. LKM512 supplementation ameliorates hepatic lipid accumulation, attenuates hepatic and adipose tissue inflammation, and improves intestinal barrier function. These results are associated with improved insulin sensitivity and metabolic endotoxemia. Furthermore, the colonization of LKM512 induces an increase in polyamine metabolism and production, together with significant alternations in the composition and function of gut microbiota in obese mice, which are correlated with these improved metabolic phenotypes in the host. CONCLUSION: The probiotic strain LKM512 may become a promising strategy to improve obesity and related metabolic disorders.
Subject(s)
Bifidobacterium animalis , Gastrointestinal Microbiome , Insulin Resistance , Probiotics , Animals , Bifidobacterium/metabolism , Diet, High-Fat/adverse effects , Feces/microbiology , Inflammation , Mice , Mice, Inbred C57BL , Mice, Obese , Obesity/etiology , Probiotics/pharmacologyABSTRACT
SCOPE: Irregular eating habits, such as late-night eating, will cause increased risk of obesity and other metabolic diseases. The aim of this study is to elucidate the impacts of late-night eating on physiological function and gut microbiota. METHODS AND RESULTS: Male Wistar rats under 16 h/8 h-light/dark cycle are divided into four groups with specific dietary habits, which mimicked breakfast, lunch, dinner, and late-night eating. Late-night eating, including skipping dinner for a night eating (BLN) and skipping breakfast and having a night eating (LDN), causes an increase of body weight, which is associated with decreased physical activity. Additionally, late-night eating results in hepatic lipid accumulation and systemic inflammation in peripheral tissues, compared to those of free feeding (FF) or breakfast, lunch, and dinner (BLD) groups. The phases of key clock genes are similar in FF, BLD, and BLN groups, while LDN feeding causes an overall 4 h phase delay in peripheral tissues. Moreover, late-night eating, especially LDN feeding, results in a significant alternation in the compositions and functions of gut microbiota, which further contributes to the development of metabolic disorder. CONCLUSION: Late-night eating causes physiological dysregulation and misalignment of circadian rhythm, together with microbial dysbiosis.
Subject(s)
Circadian Rhythm/physiology , Dysbiosis , Feeding Behavior , Gastrointestinal Microbiome/physiology , Animals , Inflammation/etiology , Male , Motor Activity , Obesity/etiology , Rats , Rats, WistarABSTRACT
SCOPE: Age-related degeneration is associated with imbalances of gut microbiota and its related immune system, thus gut microbiota dysbiosis is considered to be a key target to improve senescence. The potential roles of probiotics on physiological function and cognitive ability in aged mice are investigated in this study. METHODS AND RESULTS: Lactobacillus casei LC122 or Bifidobacterium longum BL986, are orally administrated for 12 weeks, and the anti-aging effects, as well as the composition and function of gut microbiota, are investigated in aged mice. Probiotics supplementation ameliorates hepatic lipid accumulation, enhances muscle strength and function, attenuates oxidative stress and inflammation in peripheral tissues, and improves gut barrier function. These results are associated with improved learning and memory ability as assessed by behavioral tests and upregulation of neurodegenerative and neurotrophic factors expressions in hippocampus. Moreover, the diversity and composition of gut microbiota are altered in aged mice, and both probiotics treatment display distinguished features of gut microbiota. Comparisons of two probiotic strains reveal significant differences in the taxa at family and genus level, leading to the functional profile change of the microbial community. CONCLUSION: L. casei LC122 and B. longum BL986 might be used as novel and promising anti-aging agents in human.